| Primary |
| Product Used For Unknown Indication |
35.2% |
| Seasonal Allergy |
10.0% |
| Hypersensitivity |
9.9% |
| Drug Use For Unknown Indication |
5.1% |
| Rhinitis Allergic |
5.0% |
| Pruritus |
4.7% |
| Acarodermatitis |
4.5% |
| Multiple Allergies |
4.4% |
| Urticaria |
4.4% |
| Hypertension |
2.6% |
| Asthma |
1.9% |
| Pain |
1.8% |
| Allergic Sinusitis |
1.5% |
| Diffuse Cutaneous Mastocytosis |
1.4% |
| Conjunctivitis |
1.3% |
| Contraception |
1.3% |
| Depression |
1.3% |
| Prophylaxis |
1.3% |
| Rhinitis |
1.3% |
| Swelling |
1.3% |
|
| Urticaria |
11.0% |
| Maternal Drugs Affecting Foetus |
9.6% |
| Convulsion |
7.7% |
| Drug Exposure During Pregnancy |
7.7% |
| Hepatitis |
5.7% |
| Epilepsy |
5.3% |
| Pruritus |
5.3% |
| Hepatotoxicity |
4.8% |
| Rash |
4.8% |
| Suicidal Ideation |
4.3% |
| Vomiting |
4.3% |
| Dystonia |
3.8% |
| Malaise |
3.8% |
| Angioedema |
3.3% |
| Myasthenia Gravis |
3.3% |
| Palpitations |
3.3% |
| Pregnancy With Injectable Contraceptive |
3.3% |
| Fall |
2.9% |
| Pancreatitis Acute |
2.9% |
| Premature Baby |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
39.9% |
| Drug Use For Unknown Indication |
7.9% |
| Foetal Exposure During Pregnancy |
6.2% |
| Seasonal Allergy |
4.6% |
| Asthma |
4.2% |
| Pain |
4.2% |
| Ill-defined Disorder |
3.7% |
| Hypertension |
3.3% |
| Acute Myocardial Infarction |
3.1% |
| B-cell Lymphoma |
2.9% |
| Pruritus |
2.9% |
| Hypersensitivity |
2.8% |
| Rhinitis Allergic |
2.5% |
| Eye Pruritus |
1.9% |
| Sneezing |
1.9% |
| Rhinorrhoea |
1.8% |
| Depression |
1.7% |
| Urticaria |
1.7% |
| Bronchitis |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Suicide Attempt |
9.0% |
| Fibromyalgia |
8.3% |
| Convulsion |
7.7% |
| Rash |
7.7% |
| Wrong Drug Administered |
7.7% |
| Pancreatitis Acute |
6.4% |
| Urticaria |
6.4% |
| Epilepsy |
4.5% |
| Hepatitis |
4.5% |
| Angioedema |
3.8% |
| Maternal Exposure During Pregnancy |
3.8% |
| Off Label Use |
3.8% |
| Rash Generalised |
3.8% |
| Vestibular Disorder |
3.8% |
| Cholestasis |
3.2% |
| Completed Suicide |
3.2% |
| Death |
3.2% |
| Intentional Overdose |
3.2% |
| Rash Maculo-papular |
3.2% |
| Agitation |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.4% |
| Drug Use For Unknown Indication |
20.8% |
| Asthma |
5.9% |
| Hypertension |
5.2% |
| Pain |
4.1% |
| Prophylaxis |
4.1% |
| Depression |
3.6% |
| Hypersensitivity |
3.6% |
| Rheumatoid Arthritis |
3.5% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Hiv Infection |
2.3% |
| Premedication |
2.2% |
| Seasonal Allergy |
2.1% |
| Constipation |
2.0% |
| Diabetes Mellitus |
2.0% |
| Rash |
1.7% |
| Anxiety |
1.6% |
| Insomnia |
1.4% |
| Unevaluable Event |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
|
| Vomiting |
13.8% |
| Rash |
8.1% |
| Urticaria |
7.6% |
| Pneumonia |
6.5% |
| Pyrexia |
6.0% |
| Stevens-johnson Syndrome |
4.9% |
| Nausea |
4.7% |
| Weight Decreased |
4.4% |
| Hypoglycaemia |
4.2% |
| Renal Failure |
4.2% |
| Thrombocytopenia |
4.2% |
| Pain |
3.9% |
| Tachycardia |
3.9% |
| Asthma |
3.6% |
| Drug Ineffective |
3.4% |
| Dyspnoea |
3.4% |
| Pruritus |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Wheezing |
3.4% |
| Anaphylactic Reaction |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
83.3% |
| Atrial Fibrillation |
11.1% |
| Seasonal Allergy |
5.6% |
|
| Diarrhoea |
25.0% |
| Drug Diversion |
25.0% |
| Drug Interaction |
25.0% |
| Visual Impairment |
25.0% |
|
